Palisade Bio Employee Directory
Pharmaceutical ManufacturingColorado, United States11-50 Employees
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company based in Carlsbad, California, focused on developing oral PDE4 inhibitor prodrugs for inflammatory and fibrotic diseases. Its lead program, PALI-2108, is a once-daily oral prodrug designed to be selectively activated in the ileum and colon, enabling targeted inhibition at disease sites with systemic distribution of the active drug. PALI-2108 has shown positive results in Phase 1 trials conducted in ulcerative colitis and fibrostenotic Crohn's disease, and the company is moving toward Phase 2 studies in ulcerative colitis and Crohn's disease. The company operates within the pharmaceutical manufacturing sector and is publicly traded on Nasdaq under the ticker PALI.